Vesigen proposal selected as a “Winning Solution" for programmable delivery systems for gene editingProposal builds on recent data demonstrating cell type-specific targeting of Company’s non-viral delivery platformCAMBRIDGE, Mass. (BUSINESS WIRE) #ARMMs Vesigen Therapeutics, Inc., a biotechnology company developi.
Vesigen Receives National Institutes of Health Award in Targeted Genome Editor Delivery Challenge lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Hereditary Disease Foundation Announces Recipients of Inaugural Transformative Research Award streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass. (BUSINESS WIRE) Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today showcased new data at the Exosome Based Therapeutic Development Summit 5th Annual Meeting held September 5-7, 2023 in Bost.